Hear from us

    29 November 2023

    Orphelia Pharma secures US patent covering KIZFIZO®, first drinkable formulation of temozolomide

    Read More >
    28 November 2023

    ORPHELIA Pharma to support the European paediatric Soft Tissue Sarcoma Study Group winter meeting.

    Read More >
    2 November 2023

    Medicines for Europe : 5th Value Added Medicines Conference, 7th November 2023, Brussels

    Read More >
    30 October 2023

    Event : BioEurope Fall 2023 (November 6-8, 2023; Munich, Germany) 

    Read More >
    24 October 2023

    Orphelia Pharma dépose une demande d’autorisation de mise sur le marché en Europe pour KIZFIZO®

    Read More >
    24 October 2023

    Orphelia Pharma files EU marketing authorization application for KIZFIZO®

    Read More >